|
1
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kerbel RS: Tumor angiogenesis: Past,
present and the near future. Carcinogenesis. 21:505–515. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alon T, Hemo I, Itin A, Pe'er J, Stone J
and Keshet E: Vascular endothelial growth factor acts as a survival
factor for newly formed retinal vessels and has implications for
retinopathy of prematurity. Nat Med. 1:1024–1028. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrara N: Vascular endothelial growth
factor: Molecular and biological aspects. Curr Top Microbiol
Immunol. 237:1–30. 1999.PubMed/NCBI
|
|
5
|
Dvorak HF, Brown LF, Detmar M and Dvorak
AM: Vascular permeability factor/vascular endothelial growth
factor, microvascular hyperpermeability, and angiogenesis. Am J
Pathol. 146:1029–1039. 1995.PubMed/NCBI
|
|
6
|
Dimmeler S, Fleming I, Fisslthaler B,
Hermann C, Busse R and Zeiher AM: Activation of nitric oxide
synthase in endothelial cells by Akt-dependent phosphorylation.
Nature. 399:601–605. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferrara N and Kerbel RS: Angiogenesis as a
therapeutic target. Nature. 438:967–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng X, Li A, Zhao L, Zhou T, Shen Q, Cui
Q and Qin X: Key role of microRNA-15a in the KLF4 suppressions of
proliferation and angiogenesis in endothelial and vascular smooth
muscle cells. Biochem Biophys Res Commun. 437:625–631. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roberts JM, Koff A, Polyak K, Firpo E,
Collins S, Ohtsubo M and Massagué J: Cyclins, Cdks, and cyclin
kinase inhibitors. Cold Spring Harb Symp Quant Biol. 59:31–38.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kwon HJ, Hong YK, Park C, Choi YH, Yun HJ,
Lee EW and Kim BW: Widdrol induces cell cycle arrest, associated
with MCM down-regulation, in human colon adenocarcinoma cells.
Cancer Lett. 290:96–103. 2010. View Article : Google Scholar
|
|
13
|
Kwon HJ, Lee EW, Hong YK, Yun HJ and Kim
BW: Widdrol from Juniperus chinensis induces apoptosis in human
colon adenocarcinoma HT29 cells. Biotechnol Bioprocess Eng.
15:167–172. 2010. View Article : Google Scholar
|
|
14
|
Martínez-Poveda B, Muñoz-Chápuli R,
Rodríguez-Nieto S, Quintela JM, Fernández A, Medina MA and Quesada
AR: IB05204, a dichloropyridodithienotriazine, inhibits
angiogenesis in vitro and in vivo. Mol Cancer Ther. 6:2675–2685.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Argov M, Kashi R, Peer D and Margalit R:
Treatment of resistant human colon cancer xenografts by a
fluoxetine-doxorubicin combination enhances therapeutic responses
comparable to an aggressive bevacizumab regimen. Cancer Lett.
274:118–125. 2009. View Article : Google Scholar
|
|
16
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29(Suppl 16): 15–18. 2002.
View Article : Google Scholar
|
|
17
|
He D, Jin J, Zheng Y, Bruce IC, Tam S and
Ma X: Anti-angiogenesis effect of trichosanthin and the underlying
mechanism. Biochem Biophys Res Commun. 430:735–740. 2013.
View Article : Google Scholar
|
|
18
|
Rössler J, Taylor M, Geoerger B, Farace F,
Lagodny J, Peschka-Süss R, Niemeyer CM and Vassal G: Angiogenesis
as a target in neuroblastoma. Eur J Cancer. 44:1645–1656. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shizukuda Y, Tang S, Yokota R and Ware JA:
Vascular endothelial growth factor-induced endothelial cell
migration and proliferation depend on a nitric oxide-mediated
decrease in protein kinase Cdelta activity. Circ Res. 85:247–256.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taimeh Z, Loughran J, Birks EJ and Bolli
R: Vascular endothelial growth factor in heart failure. Nat Rev
Cardiol. 10:519–530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eskens FA and Verweij J: The clinical
toxicity profile of vascular endothelial growth factor (VEGF) and
vascular endothelial growth factor receptor (VEGFR) targeting
angiogenesis inhibitors; a review. Eur J Cancer. 42:3127–3139.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saraswati S, Kanaujia PK, Kumar S, Kumar R
and Alhaider AA: Tylophorine, a phenanthraindolizidine alkaloid
isolated from Tylophora indica exerts antiangiogenic and antitumor
activity by targeting vascular endothelial growth factor receptor
2-mediated angiogenesis. Mol Cancer. 12:822013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi S: Vascular endothelial growth
factor (VEGF), VEGF receptors and their inhibitors for
antiangiogenic tumor therapy. Biol Pharm Bull. 34:1785–1788. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng JQ, Lindsley CW, Cheng GZ, Yang H
and Nicosia SV: The Akt/PKB pathway: Molecular target for cancer
drug discovery. Oncogene. 24:7482–7492. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang BH and Liu LZ: AKT signaling in
regulating angiogenesis. Curr Cancer Drug Targets. 8:19–26. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yue GG, Chan BC, Kwok HF, Wong YL, Leung
HW, Ji CJ, Fung KP, Leung PC, Tan NH and Lau CB: Anti-angiogenesis
and immunomodulatory activities of an anti-tumor sesquiterpene
bigelovin isolated from Inula helianthus-aquatica. Eur J Med Chem.
59:243–252. 2013. View Article : Google Scholar
|
|
27
|
Hong SW, Jung KH, Lee HS, Son MK, Yan HH,
Kang NS, Lee J and Hong SS: SB365, Pulsatilla saponin D, targets
c-Met and exerts antiangiogenic and antitumor activities.
Carcinogenesis. 34:2156–2169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Ma W and Zheng W: Deguelin, a
novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest
and anti-angiogenesis for cancer chemoprevention. Mol Clin Oncol.
1:215–219. 2013.
|
|
29
|
Xiao D and Singh SV: Phenethyl
isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer
Res. 67:2239–2246. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu JX, Luo MQ, Xia M, Wu Q, Long SM, Hu
Y, Gao GC, Yao XL, He M, Su H, et al: Marine compound catunaregin
inhibits angiogenesis through the modulation of phosphorylation of
akt and eNOS in vivo and in vitro. Mar Drugs. 12:2790–2801. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Favot L, Keravis T and Lugnier C:
Modulation of VEGF-induced endothelial cell cycle protein
expression through cyclic AMP hydrolysis by PDE2 and PDE4. Thromb
Haemost. 92:634–645. 2004.PubMed/NCBI
|
|
32
|
Shi F, Wang YC, Zhao TZ, Zhang S, Du TY,
Yang CB, Li YH and Sun XQ: Effects of simulated microgravity on
human umbilical vein endothelial cell angiogenesis and role of the
PI3K-Akt-eNOS signal pathway. PLoS One. 7:e403652012. View Article : Google Scholar : PubMed/NCBI
|
